Nonpharmacologic Therapy for Idiopathic Pulmonary Fibrosis

Leann L. Silhan, Sonye K. Danoff

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The care of patients with idiopathic pulmonary fibrosis requires multidisciplinary management integrating disease-specific therapy with treatment of comorbidities as well as symptom palliation. This review focuses on the role of nonpharmacologic therapy in the care of patients with idiopathic pulmonary fibrosis and describes the integration of this aspect of care in the overall patient-centered model. Nonpharmacologic care in idiopathic pulmonary fibrosis (IPF) is focused primarily on symptom management and falls in the realm of palliative care. This includes interventions to abate disease-specific symptoms such as cough and dyspnea, as well as more general comorbidities such as gastroesophageal reflux disease, fatigue, depression, and anxiety. Another aspect of nonpharmacologic therapy for IPF is lung transplantation for carefully selected individuals. Patient-centered care for IPF requires thoughtful consideration of disease-specific management, symptom management, and management of comorbidities. Central to this process are communication between the patient and provider and engagement of the patient to determine individualized goals of treatment. This approach should include nonpharmacologic therapies, as well as consideration of lung transplantation in a small group of patients.

Original languageEnglish (US)
Title of host publicationInterstitial Lung Disease
PublisherElsevier Inc.
Pages65-74
Number of pages10
ISBN (Electronic)9780323480253
ISBN (Print)9780323480246
DOIs
StatePublished - Mar 6 2017

Fingerprint

Idiopathic Pulmonary Fibrosis
Comorbidity
Lung Transplantation
Disease Management
Patient Care
Therapeutics
Patient Participation
Patient-Centered Care
Gastroesophageal Reflux
Palliative Care
Cough
Dyspnea
Fatigue
Anxiety
Communication
Depression

Keywords

  • Cough
  • Depression
  • Dyspnea
  • Fatigue
  • Gastroesophageal reflux disease
  • Lung transplantation
  • Palliation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Silhan, L. L., & Danoff, S. K. (2017). Nonpharmacologic Therapy for Idiopathic Pulmonary Fibrosis. In Interstitial Lung Disease (pp. 65-74). Elsevier Inc.. https://doi.org/10.1016/B978-0-323-48024-6.00005-7

Nonpharmacologic Therapy for Idiopathic Pulmonary Fibrosis. / Silhan, Leann L.; Danoff, Sonye K.

Interstitial Lung Disease. Elsevier Inc., 2017. p. 65-74.

Research output: Chapter in Book/Report/Conference proceedingChapter

Silhan, Leann L. ; Danoff, Sonye K. / Nonpharmacologic Therapy for Idiopathic Pulmonary Fibrosis. Interstitial Lung Disease. Elsevier Inc., 2017. pp. 65-74
@inbook{5ec36bd8907e46798d1b7f8f66393b90,
title = "Nonpharmacologic Therapy for Idiopathic Pulmonary Fibrosis",
abstract = "The care of patients with idiopathic pulmonary fibrosis requires multidisciplinary management integrating disease-specific therapy with treatment of comorbidities as well as symptom palliation. This review focuses on the role of nonpharmacologic therapy in the care of patients with idiopathic pulmonary fibrosis and describes the integration of this aspect of care in the overall patient-centered model. Nonpharmacologic care in idiopathic pulmonary fibrosis (IPF) is focused primarily on symptom management and falls in the realm of palliative care. This includes interventions to abate disease-specific symptoms such as cough and dyspnea, as well as more general comorbidities such as gastroesophageal reflux disease, fatigue, depression, and anxiety. Another aspect of nonpharmacologic therapy for IPF is lung transplantation for carefully selected individuals. Patient-centered care for IPF requires thoughtful consideration of disease-specific management, symptom management, and management of comorbidities. Central to this process are communication between the patient and provider and engagement of the patient to determine individualized goals of treatment. This approach should include nonpharmacologic therapies, as well as consideration of lung transplantation in a small group of patients.",
keywords = "Cough, Depression, Dyspnea, Fatigue, Gastroesophageal reflux disease, Lung transplantation, Palliation",
author = "Silhan, {Leann L.} and Danoff, {Sonye K.}",
year = "2017",
month = "3",
day = "6",
doi = "10.1016/B978-0-323-48024-6.00005-7",
language = "English (US)",
isbn = "9780323480246",
pages = "65--74",
booktitle = "Interstitial Lung Disease",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Nonpharmacologic Therapy for Idiopathic Pulmonary Fibrosis

AU - Silhan, Leann L.

AU - Danoff, Sonye K.

PY - 2017/3/6

Y1 - 2017/3/6

N2 - The care of patients with idiopathic pulmonary fibrosis requires multidisciplinary management integrating disease-specific therapy with treatment of comorbidities as well as symptom palliation. This review focuses on the role of nonpharmacologic therapy in the care of patients with idiopathic pulmonary fibrosis and describes the integration of this aspect of care in the overall patient-centered model. Nonpharmacologic care in idiopathic pulmonary fibrosis (IPF) is focused primarily on symptom management and falls in the realm of palliative care. This includes interventions to abate disease-specific symptoms such as cough and dyspnea, as well as more general comorbidities such as gastroesophageal reflux disease, fatigue, depression, and anxiety. Another aspect of nonpharmacologic therapy for IPF is lung transplantation for carefully selected individuals. Patient-centered care for IPF requires thoughtful consideration of disease-specific management, symptom management, and management of comorbidities. Central to this process are communication between the patient and provider and engagement of the patient to determine individualized goals of treatment. This approach should include nonpharmacologic therapies, as well as consideration of lung transplantation in a small group of patients.

AB - The care of patients with idiopathic pulmonary fibrosis requires multidisciplinary management integrating disease-specific therapy with treatment of comorbidities as well as symptom palliation. This review focuses on the role of nonpharmacologic therapy in the care of patients with idiopathic pulmonary fibrosis and describes the integration of this aspect of care in the overall patient-centered model. Nonpharmacologic care in idiopathic pulmonary fibrosis (IPF) is focused primarily on symptom management and falls in the realm of palliative care. This includes interventions to abate disease-specific symptoms such as cough and dyspnea, as well as more general comorbidities such as gastroesophageal reflux disease, fatigue, depression, and anxiety. Another aspect of nonpharmacologic therapy for IPF is lung transplantation for carefully selected individuals. Patient-centered care for IPF requires thoughtful consideration of disease-specific management, symptom management, and management of comorbidities. Central to this process are communication between the patient and provider and engagement of the patient to determine individualized goals of treatment. This approach should include nonpharmacologic therapies, as well as consideration of lung transplantation in a small group of patients.

KW - Cough

KW - Depression

KW - Dyspnea

KW - Fatigue

KW - Gastroesophageal reflux disease

KW - Lung transplantation

KW - Palliation

UR - http://www.scopus.com/inward/record.url?scp=85040199425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040199425&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-48024-6.00005-7

DO - 10.1016/B978-0-323-48024-6.00005-7

M3 - Chapter

AN - SCOPUS:85040199425

SN - 9780323480246

SP - 65

EP - 74

BT - Interstitial Lung Disease

PB - Elsevier Inc.

ER -